Firas El Chaer - University of Virginia

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 90 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Managing infectious challenges in the age of molecular-targeted therapies for adult hematological malignancies

Manan Shah,Firas El Chaer,Dora Y. Ho,Zeinab El Boghdadly

TRANSPLANT INFECTIOUS DISEASEno. 3 (2024): e14283-e14283

引用0浏览0WOS引用

Clinical Outcomes of Patients Receiving Venetoclax and Hypomethylating Agents for AML in Academic and Academic-Community Partnerships

Natalie Pham,Jeffrey Lantz,Caroline Jones,Debamita Kundu, Nicholas McCann,Firas El Chaer,Daniel Reed,Michael Kenneth Keng

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Plurality over Parsimony: when Two Diagnoses Are More Likely Than One

Jasraj S. Raghuwanshi, Nathan Roberts,Thomas P. Loughran Jr.,Firas El Chaer, Mark Girton,Glenn Moulder

JOURNAL OF GENERAL INTERNAL MEDICINEno. 7 (2024): 1257-1263

引用0浏览0WOS引用

MRD in Philadelphia Chromosome-Positive ALL: Methodologies and Clinical Implications

Valerie Tran, Kiarash Salafian, Kenan Michaels,Caroline Jones,Daniel Reed,Michael Keng,Firas El Chaer

Current hematologic malignancy reportsno. 4 (2024): 186-196

引用0浏览0WOS引用

Managing Infectious Challenges in the Age of Molecular‐targeted Therapies for Adult Hematological Malignancies

Manan Shah,Firas El Chaer,Dora Y. Ho,Zeinab El Boghdadly

Transplant infectious disease (2024)

引用0浏览0引用

Treatment Outcomes with Hypomethylating Agents and Venetoclax for AML in the Community Compared to an Academic Setting

Lantz Jeffrey,Natalie Pham,Caroline Jones,Debamita Kundu, Nicholas McCann,Firas El Chaer,Daniel Reed,Michael Keng

Blood（2023）

引用0浏览0引用

P1031: PRELIMINARY DATA FROM THE PHASE 1/2 STUDY OF TP-3654, AN INVESTIGATIONAL SELECTIVE PIM1 KINASE INHIBITOR, SHOWED CYTOKINE REDUCTION AND CLINICAL RESPONSES IN RELAPSED/REFRACTORY MYELOFIBROSIS

Firas El Chaer,Lindsay Rein,Kazuya Shimoda,Junichiro Yuda,Tamanna Haque,James McCloskey,Akiyoshi Takami,Masafumi Fukaya,Shuichi Shirane,Sujan Kabir,Jian Mei,Z. Li,Mark Wade,Claudia Lebedinsky,Raajit K. Rampal

HemaSphere（2023）

引用0浏览0引用

POSTER: MPN-439 Preliminary Data From the Phase 1/2 Study of TP-3654, an Investigational Selective PIM1 Kinase Inhibitor, Showed Cytokine Reduction and Clinical Responses in Relapsed/Refractory Myelofibrosis (MF)

Firas El Chaer,Lindsay Rein,Kazuya Shimoda,Junichiro Yuda,Tamanna Haque, James McCloskey, Akiyoshi Takami,Masafumi Fukaya,Shuichi Shirane,Sujan Kabir,Jian Mei, Masataka Seki, Zhonggai Li,Mark Wade,Claudia Lebedinsky,Raajit K Rampal

Clinical Lymphoma Myeloma and Leukemia (2023)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn